VIZ ACCESS HCM - Multi-Site Registry
ConditionHypertrophic Cardiomyopathy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorViz.ai, Inc.
About this trial
To describe the clinical, economic, and population characteristics of newly diagnosed, previously diagnosed, and suspected patients evaluated by Viz HCM. HCM is underdiagnosed in the community and AI algorithms have been developed as screening tools. However, it is not well understood how to best integrate AI screening tools and their potential impact.
Eligibility criteria
Qualifiers
Patients aged 18+ years at time of arrival to healthcare facility
Patients with a resting 12-lead digital electrocardiogram (ECG) that is flagged by Viz HCM for HCM suspicion
Patients have been diagnosed with HCM after the Viz HCM implementation
Written informed consent is obtained prior to data collection
Disqualifiers
None
Trial design
Treatments tested in this trial
- Viz HCM
Treatment groups
500 Participants
are divided into 5 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov